Leadership
GBM AGILE
About GBM AGILE
GBM AGILE Trial Sites
FAQs
Strategic Partners
REMAP-COVID
About REMAP-COVID
REMAP-COVID US Trial Sites
Ovarian CanceRx
News
Join Us
Contact
DONATE
< Back to News
Kintara Announces First International Site Activation in GCAR Phase 2/3 Clinical Trial for Glioblastoma
NOVEMBER 30, 2021 | PRNEWSWIRE
https://www.kintara.com/news-media/press-releases/detail/981/kintara-announces-first-international-site-activation-in
Home
Leadership
About REMAP-COVID
REMAP-COVID US Trial Sites
Ovarian CanceRx
GBM AGILE
About GBM AGILE
GBM AGILE Trial Sites
FAQs
Strategic Partners
News
Join Us
Contact
DONATE